Form 4 for HCA HCA Healthcare
Accepted 2024-02-06 00:00:00 ET · period of report 2024-02-02 · accession 0001209191-24-002937 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-02-06 | 2024-02-02 | HCA | RUTHERFORD BILL B | CFO, EVP | F - Tax | $309.42 | -9,652 | 15.8K | -38% | -$2.99M |
| D | 2024-02-06 | 2024-02-06 | HCA | RUTHERFORD BILL B | CFO, EVP | S - Sale+OE | $310.63 | -6,000 | 8,448 | -42% | -$1.86M |
| DM | 2024-02-06 | 2024-02-05 | HCA | RUTHERFORD BILL B | CFO, EVP | G - Gift | $0.00 | -1,369 | 15.6K | -8% | $0 |
| DI | 2024-02-06 | 2024-02-05 | HCA | RUTHERFORD BILL B | CFO, EVP | G - Gift | $0.00 | +1,194 | 19.8K | +6% | $0 |
| D | 2024-02-06 | 2024-02-02 | HCA | RUTHERFORD BILL B | CFO, EVP | M - OptEx | $69.58 | +19.1K | 25.5K | +300% | +$1.33M |
| D | 2024-02-06 | 2024-02-02 | HCA | RUTHERFORD BILL B | CFO, EVP | M - OptEx | $0.00 | -19.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-02 | F | D | 9,652 | $309.42 | 15,817 | D | — | — | |
| 2 | Common | Common Stock | 2024-02-06 | S | D | 6,000 | $310.63 | 8,448 | D | — | — | |
| 3 | Common | Common Stock | 2024-02-05 | G | D | 1,194 | $0.00 | 14,448 | D | — | — | |
| 4 | Common | Common Stock | 2024-02-05 | G | A | 1,194 | $0.00 | 19,834 | I | — | — | |
| 5 | Common | Common Stock | 2024-02-02 | M | A | 19,100 | $69.58 | 25,469 | D By Family Trust | — | — | |
| 6 | Common | Common Stock | 2024-02-05 | G | D | 175 | $0.00 | 15,642 | D | — | — | |
| 7 | Derivative | Stock Appreciation Right | 2024-02-02 | M | D | 19,100 | $0.00 | 0 | D | $69.58 · — to 2026-01-29 | 19,100 Common Stock | (F1) The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. |